DaVita (DVA) Stock Forecast & Price Target

DVA price $193.61 +9.68 +5.26%

Ticker
DVA
Price
$193.61
Change
+9.68 +5.26%
Market cap ?
$12.35B
P/E ?
15.82
Forward P/E ?
13.06
Dividend yield ?
0.00%
Beta ?
0.80
Sector
Healthcare
Industry
Medical - Care Facilities
Stocklytics score
62
Value
75
Quality
53
Growth
58

Stocklytics score rationale: value 75, quality 53, growth 58.

Financials

2016201720182019202020212022202320242025
14745105000108766340001140485100011388479000115506040001161879700011609894000121401470001281555000013643069000

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic…

Forecast

Consensus Hold from 8 analysts. Average price target $235.67, +21.7% versus the current price. Low $215.00. High $270.00.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Analysts have an average 12-month price target of $235.67 for DaVita (DVA), 21.7% above the current price of $193.61. Of 8 analysts covering the stock, 3 rate it Buy or Strong Buy, 4 Hold, and 1 Sell or Strong Sell, giving a consensus of Hold.

Forecasts are third-party estimates and often wrong. They are not investment advice.

DVA price target

12-month price target
Low$215.00
Average$235.67
High$270.00

The average is 21.7% above the current price of $193.61.

Is DaVita a buy or sell?

Of 8 analysts, 3 rate DaVita Buy or Strong Buy, 4 Hold, and 1 Sell or Strong Sell. The consensus label is Hold. That split is not a recommendation.

DaVita earnings and revenue forecast

Analyst averages on file: 2026, EPS $14.82, revenue $14.10 billion. 2027, EPS $16.96, revenue $14.53 billion.

DVA score and fair value

The Stocklytics Score for DVA is 62 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.

DVA forecast FAQs

What is the DVA price target?

$235.67 average, with a published range of $215.00 to $270.00.

Is DaVita a buy or sell?

The consensus is Hold from 8 analysts. This is not a recommendation.

What is the DaVita stock forecast for 2026?

Analysts' average EPS estimate for 2026 on file is $14.82. The average revenue estimate is $14.10 billion.

What will DVA be worth in 2030?

No reliable forecast exists that far out.

When is DaVita's next earnings report?

The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.

Related: DaVita · Financials · Dividends · Compare · AI stocks

Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.

DaVita (DVA) Stock Forecast & Price Target

DVA$193.61+9.68 +5.26%

$12.35B

Market Cap

15.82

P/E

13.06

Forward P/E

62

Score

Price History